💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Ignyta, Inc. (RXDX)
« Back to company indexRXDX Chatter Timeline
Stock Ticker for RXDX
Most Active Tweeters for RXDX
| User | Tweets |
|---|---|
| @shortablestocks | 2 |
| @AlertTrade | 1 |
| @QuantchaIdeas | 1 |
| @kwhenfinance | 1 |
| @MarcJacksonLA | 1 |
Recent Tweets for RXDX
 |
@quantisnow $RXDX ? SEC Form 4: Mckenna Mark C. exercised 15,400 shares at a strike of $2.90 https://t.co/tHNybBSRyx 45 secon… https://t.co/Dun0dFtfub 12:12am |
 |
@MarcJacksonLA $RXDX Prometheus Biosciences Inc Shares Close the Week 21.3% Lower - Weekly Wrap | NASDAQ https://t.co/vvn4r8srzN November 27th 2021, 4:11pm |
 |
@kwhenfinance Prometheus Biosciences Inc Shares Close the Week 21.3% Lower - Weekly Wrap https://t.co/5HAj7aifxR $RXDX #stockmarket #kwhenfinance November 26th 2021, 11:11pm |
 |
@QuantchaIdeas Big Gainer Alert: Trading today’s 9.1% move in PROMETHEUS BIOSCIENCES INC. COMMON STOCK $RXDX https://t.co/33ue8txjeZ November 24th 2021, 5:11pm |
 |
@shortablestocks $RXDX is short sale restricted for 2021-11-24. https://t.co/rV9s3JqBvN November 24th 2021, 2:11pm |
|
@shortablestocks $RXDX is short sale restricted for 2021-11-23. https://t.co/rV9s3JqBvN November 23rd 2021, 2:11pm |
 |
@AlertTrade DOWNSIDE MOMO: $RXDX Prometheus Biosciences, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 22nd 2021, 3:11pm |
 |
@mehabecapital Stocks in Top Losers today: $RXDX, Current Price: $31.96, Change today: -16.23%, Total Traded Volume: 52333 https://t.co/RcMaUEblKA November 22nd 2021, 3:11pm |
 |
@MaxJacobsEdison Anyone know why $RXDX is down 19%? I don't see any news. Or is it just another "Welcome to Biotech" moment? November 22nd 2021, 3:11pm |
 |
@ShortAlgoTrades $RXDX Awaiting Short Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/iTqZlBMJF7 November 19th 2021, 2:11pm |
 |
@StockTipRobot If you are looking for advice on #Stonks, you've come to the right place. Now sell your human children and buy Ignyta $RXDX #ProTip November 18th 2021, 5:11pm |
 |
@Uncletrade1 $RXDX Waiting for Short signal on RXDX https://t.co/LaJ5eUswVi November 18th 2021, 4:11pm |
 |
@A1Syad $RXDX Awaiting Short Signal. Algo Trading by https://t.co/1MjnDHV7ua https://t.co/9N09MySovt November 18th 2021, 2:11pm |
 |
@pennies_pretty $RXDX Broke out of a small flag on the daily to hit new all time highs. https://t.co/z2GAbb6eoz November 18th 2021, 1:11pm |
|
@MarcJacksonLA $RXDX Prometheus Biosciences Given Average Recommendation of "Buy" by Brokerages | $38.60 Average PT… https://t.co/G11YGcVqPm November 18th 2021, 11:11am |
|
@Uncletrade1 $RXDX Waiting for Short signal on RXDX https://t.co/JJEbdvjmmb November 17th 2021, 2:11pm |
|
@quantisnow $RXDX ? SEC Form 4 filed by Mckenna Mark C. https://t.co/3FQqKk38qv 45 seconds delayed. November 17th 2021, 2:11am |
 |
@Briefingcom $RXDX: Oppenheimer cuts to Perform https://t.co/7Fv1ZiFZBS November 15th 2021, 2:11pm |
|
@Briefingcom $RXDX: Oppenheimer cuts to Perform November 15th 2021, 12:11pm |
 |
@Jarvis_Alerts $RXDX [Prometheus Biosciences]: SVB Leerink Maintains Outperform Raises Price Target $34 --> 43 Sign-up free for… https://t.co/gwiqlHz1RI November 15th 2021, 12:11pm |
|
@Jarvis_Alerts $RXDX [Prometheus Biosciences]: Oppenheimer Downgrades Outperform --> Perform Sign-up free for beta ver.:… https://t.co/SHfebZRsDH November 15th 2021, 12:11pm |
 |
@63_hyacinth Prometheus downgraded to Perform from Outperform at Oppenheimer $RXDX November 15th 2021, 10:11am |
|
@quantisnow $RXDX ? Prometheus Biosciences downgraded by Oppenheimer https://t.co/UtIckYtVsp 45 seconds delayed. November 15th 2021, 10:11am |
 |
@MarketNFlash Oppenheimer Downgrades Prometheus Biosciences to Perform | $RXDX November 15th 2021, 10:11am |
 |
@newsfilterio $RXDX Oppenheimer analyst Jeff Jones downgrades Prometheus Biosciences from Outperform to Perform. November 15th 2021, 10:11am |
|
@quantisnow $RXDX ? SVB Leerink reiterated coverage on Prometheus Biosciences with a new price target https://t.co/K7Cwa40kyI 45 seconds delayed. November 15th 2021, 10:11am |
 |
@ChartMill $RXDX has an Altman-Z score of 27.74, meaning it is financially healthy with little risk of bankruptcy.… https://t.co/vyaqTxcEja November 14th 2021, 2:11pm |
|
@newsfilterio Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Progress $RXDX https://t.co/pHYuE1CAcH November 13th 2021, 1:11am |
|
@AlertTrade DOWNwithEARNINGS: $RXDX Prometheus Biosciences, Inc. ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 12th 2021, 3:11pm |
|
@MarcJacksonLA $RXDX Stifel Nicolaus Initiates Coverage On Prometheus Biosciences With A Buy Rating, $37 PT https://t.co/xKruSlBFiq November 12th 2021, 3:11pm |
|
@MarcJacksonLA $RXDX Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Corporate Update https://t.co/qeZAI3PfLL via @Bakersfieldcali November 12th 2021, 2:11pm |
 |
@StckPro $RXDX NEW ARTICLE : Prometheus Biosciences EPS misses by $0.12, beats on revenue https://t.co/V8OjdPs4X2 Get all th… https://t.co/IKjtOMJ3NK November 12th 2021, 1:11pm |
|
@63_hyacinth Prometheus announces upcoming milestones $RXDX November 12th 2021, 1:11pm |
 |
@FlashAlert_me $RXDX [15s. delayed]: Issued Press Release on November 12, 08:00:00: Prometheus Biosciences Reports Third Quarter 2… https://t.co/Dvbrc8MpVp November 12th 2021, 1:11pm |
 |
@phasefivebot $RXDX Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/jLJD0910Sv November 12th 2021, 1:11pm |
 |
@StockNewsBot2 $RXDX Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/tilSN6zXmo November 12th 2021, 1:11pm |
 |
@stock_titan $RXDX Prometheus Biosciences Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Progress https://t.co/JFfhjUK2Wm November 12th 2021, 1:11pm |
|
@63_hyacinth Prometheus resumed with a Buy at Stifel $RXDX November 12th 2021, 12:11pm |
 |
@stockmktgenius $RXDX Prometheus Biosciences, I Top stock up 130% from low. Close: 38.00 VolvsAvg: 1.55 Liq: $13M https://t.co/sOZvUUJx5n November 10th 2021, 4:11pm |
 |
@AlphaWCX Double Inside Daily and Up: $RXDX November 8th 2021, 3:11pm |
|
@AlphaWCX Double Inside Daily: $RXDX November 8th 2021, 2:11pm |
|
@stockmktgenius $RXDX Prometheus Biosciences, I Top stock up 116% from low. Close: 35.46 VolvsAvg: 1.62 Liq: $12M https://t.co/sOZvUUJx5n November 5th 2021, 3:11pm |
|
@newsfilterio Prometheus Biosciences to Present at Upcoming Investor Conferences $RXDX https://t.co/ur4wYFDwbK November 3rd 2021, 9:11am |
 |
@hesham_monica $RXDX Awaiting Short Signal. Free Trial at https://t.co/iULkPOktMH https://t.co/BCH7K88hVr November 3rd 2021, 12:11am |
|
@ShortAlgoTrades $RXDX Awaiting Short Signal. Algo Trading by https://t.co/jpmUt7BvVp https://t.co/BZ9UjDYkrC November 2nd 2021, 1:11pm |
|
@MarcJacksonLA $RXDX Prometheus Biosciences to Present at Upcoming Investor Conferences https://t.co/0IrOdbKxPO via @Bakersfieldcali November 2nd 2021, 12:11pm |
|
@phasefivebot $RXDX Prometheus Biosciences to Present at Upcoming Investor Conferences https://t.co/RowvyZANuc November 2nd 2021, 12:11pm |
 |
@bthefirsttoknow First out// $RXDX: Prometheus Biosciences to Present at Upcoming Investor Conferences https://t.co/IJDe2MsuCV November 2nd 2021, 12:11pm |
|
@StockNewsBot2 $RXDX Prometheus Biosciences to Present at Upcoming Investor Conferences https://t.co/xvHZLdvgFC November 2nd 2021, 12:11pm |
|
@stock_titan $RXDX Prometheus Biosciences to Present at Upcoming Investor Conferences https://t.co/aNdTd3fw8j November 2nd 2021, 12:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?